On the public citation graph

A Dft Study on the Excited States and Active Sites of Gefitinib

https://doi.org/10.2139/ssrn.4673085
0 signed · 23 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

1 of the 23 references listed on this page is in the Retraction Watch database as retracted (export 2026-11-04): 10.1186/s13046-018-0845-9 (notice 2023-04-06).

Dataset join, best-effort; this page does not check the publisher record. Retraction Watch data via Crossref Labs, used with credit; OpenCitations Index (CC0) and Meta (CC BY 4.0); dataset doi:10.7910/DVN/WT8VOA (CC BY 4.0).

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/jcc.22885openalex-extracted
Multiwfn: A multifunctional wavefunction analyzer
inferredcites →https://doi.org/10.1007/s11095-015-1771-6openalex-extracted
Novel Gefitinib Formulation with Improved Oral Bioavailability in Treatment of A431 Skin Carcinoma
inferredcites →https://doi.org/10.1016/j.carbon.2020.05.023openalex-extracted
An sp-hybridized all-carboatomic ring, cyclo[18]carbon: Electronic structure, electronic spectrum, and optical nonlinearity
inferredcites →https://doi.org/10.1016/j.heliyon.2021.e06548openalex-extracted
DFT and molecular dynamics studies of astaxanthin-metal ions (Cu2+ and Zn2+) complex to prevent glycated human serum albumin from possible unfolding
inferredcites →https://doi.org/10.1016/j.ijpharm.2007.04.002openalex-extracted
Pharmacokinetics of gefitinib in humans: The influence of gastrointestinal factors
inferredcites →https://doi.org/10.1016/j.jmgm.2012.07.004openalex-extracted
Quantitative analysis of molecular surface based on improved Marching Tetrahedra algorithm
inferredcites →https://doi.org/10.1021/ct200308mopenalex-extracted
A Qualitative Index of Spatial Extent in Charge-Transfer Excitations
inferredcites →https://doi.org/10.1021/jp810292nopenalex-extracted
Universal Solvation Model Based on Solute Electron Density and on a Continuum Model of the Solvent Defined by the Bulk Dielectric Constant and Atomic Surface Tensions
inferredcites →https://doi.org/10.1038/nprot.2014.042openalex-extracted
A guide to small-molecule structure assignment through computation of (1H and 13C) NMR chemical shifts
inferredcites →https://doi.org/10.1038/s41563-020-0710-zopenalex-extracted
Highly efficient luminescence from space-confined charge-transfer emitters
inferredcites →https://doi.org/10.1038/sj.onc.1204082openalex-extracted
The EGF receptor family as targets for cancer therapy
inferredcites →https://doi.org/10.1063/1.3454683openalex-extracted
A variational formulation of the polarizable continuum model
inferredcites →https://doi.org/10.1093/annonc/mds214openalex-extracted
Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin–paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002)
inferredcites →https://doi.org/10.1097/coc.0b013e318161dc04openalex-extracted
Pilot Study of Gefitinib, Oxaliplatin, and Radiotherapy for Esophageal Adenocarcinoma
inferredcites →https://doi.org/10.1158/1078-0432.ccr-03-0564openalex-extracted
United States Food and Drug Administration Drug Approval Summary
inferredcites →https://doi.org/10.1158/1078-0432.ccr-15-2266openalex-extracted
FDA Approval of Gefitinib for the Treatment of Patients with Metastatic EGFR Mutation–Positive Non–Small Cell Lung Cancer
inferredcites →https://doi.org/10.1186/s13046-018-0845-9openalex-extracted
RETRACTED ARTICLE: Exosome-mediated transfer of lncRNA PART1 induces gefitinib resistance in esophageal squamous cell carcinoma via functioning as a competing endogenous RNA
inferredcites →https://doi.org/10.2147/ott.s221228openalex-extracted
Tanshinone IIA Reverses Gefitinib-Resistance In Human Non-Small-Cell Lung Cancer Via Regulation Of VEGFR/Akt Pathway
inferredcites →https://doi.org/10.2208/jscej.2004.778_173openalex-extracted
MEASUREMENT OF WATER CONTENTS USED MRI FOR CLAYEY SOILS ON DRYING
inferredcites →https://doi.org/10.3866/pku.whxb201401211openalex-extracted
Comparing Methods for Predicting the Reactive Site of Electrophilic Substitution
inferredcites →https://doi.org/10.3866/pku.whxb201709252openalex-extracted
Revealing Molecular Electronic Structure via Analysis of Valence Electron Density
inferredcites →https://doi.org/10.7150/jca.32989openalex-extracted
SFI Enhances Therapeutic Efficiency of Gefitinib: An Insight into Reversal of Resistance to Targeted Therapy in Non-small Cell Lung Cancer Cells
inferredcites →https://doi.org/10.7314/apjcp.2012.13.3.909openalex-extracted
Gefitinib Alone or with Concomitant Whole Brain Radiotherapy for Patients with Brain Metastasis from Non-small-cell Lung Cancer: A Retrospective Study
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.